Science gone translational: the OX40 agonist story

per Weinberg, Andrew D., Morris, Nicholas P., Kovacsovics-Bankowski, Magdalena, Urba, Walter J., Curti, Brendan D.
Publicat 2011

Development and Characterization of Recombinant Human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain

per Morris, Nicholas P., Peters, Carmen, Montler, Ryan, Hu, Hong-Ming, Curti, Brendan D., Urba, Walter J., Weinberg, Andrew D.
Publicat 2007

Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia

per Chen, Yanwen, Molloy, Sean S., Thomas, Laurel, Gambee, Jay, Bächinger, Hans Peter, Ferguson, Betsy, Zonana, Jonathan, Thomas, Gary, Morris, Nicholas P.
Publicat 2001

Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression

per Yu, Guangjie, Li, Yuhuan, Cui, Zhihua, Morris, Nicholas P., Weinberg, Andrew D., Fox, Bernard A., Urba, Walter J., Wang, Lixin, Hu, Hong-Ming
Publicat a Sci Rep (2016)

Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein

per Oberst, Michael D., Augé, Catherine, Morris, Chad, Kentner, Stacy, Mulgrew, Kathy, McGlinchey, Kelly, Hair, James, Hanabuchi, Shino, Du, Qun, Damschroder, Melissa, Feng, Hui, Eck, Steven, Buss, Nicholas, de Haan, Lolke, Pierce, Andrew J., Park, Haesun, Sylwester, Andrew, Axthelm, Michael K., Picker, Louis, Morris, Nicholas P., Weinberg, Andrew, Hammond, Scott A.
Publicat a Mol Cancer Ther (2018)